The store will not work correctly when cookies are disabled.
2,4-Dichloro-N-(1-(pyridin-4-ylmethyl)piperidin-4-yl)benzamide
ID: ALA4079046
PubChem CID: 137650102
Max Phase: Preclinical
Molecular Formula: C18H19Cl2N3O
Molecular Weight: 364.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NC1CCN(Cc2ccncc2)CC1)c1ccc(Cl)cc1Cl
Standard InChI: InChI=1S/C18H19Cl2N3O/c19-14-1-2-16(17(20)11-14)18(24)22-15-5-9-23(10-6-15)12-13-3-7-21-8-4-13/h1-4,7-8,11,15H,5-6,9-10,12H2,(H,22,24)
Standard InChI Key: FSRHDIICVIWMDM-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
38.0145 -28.9731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0133 -29.7926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7214 -30.2016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4310 -29.7922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4282 -28.9695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7196 -28.5642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7172 -27.7471 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
37.3053 -30.2007 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
40.1344 -28.5582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8436 -28.9642 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.1313 -27.7411 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.5498 -28.5529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2576 -28.9615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9617 -28.5538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9628 -27.7362 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.2537 -27.3281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5435 -27.7376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6706 -27.3276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.3783 -27.7362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.3732 -28.5532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0801 -28.9618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.7888 -28.5531 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.7861 -27.7317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0787 -27.3269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
2 8 1 0
5 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
12 13 1 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
15 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.28 | Molecular Weight (Monoisotopic): 363.0905 | AlogP: 3.78 | #Rotatable Bonds: 4 |
Polar Surface Area: 45.23 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.53 | CX Basic pKa: 7.72 | CX LogP: 2.79 | CX LogD: 2.30 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.90 | Np Likeness Score: -1.88 |
References
1. Jørgensen L, Al-Khawaja A, Kickinger S, Vogensen SB, Skovgaard-Petersen J, Rosenthal E, Borkar N, Löffler R, Madsen KK, Bräuner-Osborne H, Schousboe A, Ecker GF, Wellendorph P, Clausen RP.. (2017) Structure-Activity Relationship, Pharmacological Characterization, and Molecular Modeling of Noncompetitive Inhibitors of the Betaine/γ-Aminobutyric Acid Transporter 1 (BGT1)., 60 (21): [PMID:28991462] [10.1021/acs.jmedchem.7b00924] |